First To Know
In the news
-
NOWDx to attend AMSUS 2025 Annual Meeting March 3-5
Read MoreNOWDiagnostics (NOWDx), the manufacturer of the First To Know® Syphilis Test, will be attending the AMSUS 2025 Annual Meeting in National Harbor, MD March 3-5, 2025 at Booth #117. Join us to see the First To Know® Syphilis Test firsthand – the over-the-counter in-home syphilis test that delivers an accurate result in just 15 minutes.…
-
First To Know – the only Over-the-Counter Home Test for Syphilis – Will Now Be Available Through the National Alliance of State and Territorial AIDS Directors, Building Healthy Online Communities and the TakeMeHome Initiative
Read More– Program Provides At-Risk Consumers Access to Free Tests Delivered At Home – SPRINGDALE, ARK. – January 22, 2025 – NOWDiagnostics, Inc. (NOWDx), a leader in developing over-the-counter (OTC) and point-of-care (POC) diagnostic tests, proudly announces that its First To Know® Syphilis Test has joined the innovative TakeMeHome initiative. In collaboration with NASTAD (National Alliance…
-
NOWDiagnostics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Read MoreCEO Robert Weigle to share NOWDx’s vision for transforming consumer healthcare through in-home testing with results in minutes, and highlight commitment to advancing OTC and POC diagnostic products, including novel FDA-authorized First To Know Syphilis Test.
-
First and Only In-Home Test for Syphilis Now Available to Consumers through Major Retailers and Public Health: NOWDiagnostics Launches First To Know Syphilis Test Across the U.S.
Read MoreWith syphilis cases on the rise, NOWDx’s over-the-counter test offers rapid, in-home results in minutes and is now available nationwide in thousands of pharmacies, retail, and drugstore locations and on Amazon SPRINGDALE, Ark. – November 19, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that its First…
-
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
Read MoreAs syphilis cases surge nationwide, the collaboration will bring the First To Know over-the-counter test to clinicians and patients across professional and hospital settings NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that Labcorp, a global leader of innovative and comprehensive laboratory services, will be the exclusive U.S. distributor…
-
NOWDiagnostics First To Know Syphilis Test Receives FDA De Novo Marketing Authorization for Over-the-Counter Use
Read MoreFirst and only rapid syphilis test with in-home results in minutes, addressing growing epidemic SPRINGDALE, ARK. – August 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization to its First To Know® Syphilis Test for…